THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION

🇹🇭Thailand

Country: 🇹🇭Thailand

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Progress Adult Study

Completed

Conditions: HIV
Depression

Interventions: Drug: standard regimens according to the Thai Ministry of Public Health national guidelines

First Posted Date: 2011-04-04

Last Posted Date: 2016-05-11

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 5600

Registration Number: NCT01328275

Locations: 🇹🇭
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
🇹🇭
Sanpatong Hospital, Chiang Mai, Thailand
🇹🇭
Bamrasnaradura infectious disease institute, Nonthaburi, Thailand

Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)

Phase 3

Completed

Conditions: HIV-infected Children

Interventions: Drug: kaletra

First Posted Date: 2011-03-02

Last Posted Date: 2015-03-25

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 199

Registration Number: NCT01307124

Locations: 🇹🇭
Queen Sirikit National Institute of Child Health, Bangkok, Thailand
🇹🇭
Prapokklao Hospital, Chantaburi, Thailand
🇹🇭
Nakornping Hospital, Chiang Mai, Thailand

and more 7 locations

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Completed

Conditions: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy

Interventions: Drug: Tenofovir

First Posted Date: 2010-10-21

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 56

Registration Number: NCT01225406

Locations: 🇹🇭
Chulalongkorn University, Bangkok, Thailand
🇹🇭
HIV-NAT, Bangkok, Thailand
🇹🇭
Siriraj Hospital, Mahidol University, Bangkok, Thailand

and more 6 locations

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Phase 2

Completed

Conditions: HIV

Interventions: Drug: generic FDC of TDF/3TC/EFV

First Posted Date: 2010-07-12

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 100

Registration Number: NCT01160120

Locations: 🇹🇭
HIV-NAT, Bangkok, Thailand

Lopinavir (LPV) Dose Reduction

Phase 1

Completed

Conditions: HIV-1 Infections

Interventions: Drug: Aluvia and Generic LPV/r (pharmacokinetics)
Drug: Generic LPV/r and Aluvia (pharmacokinetics)

First Posted Date: 2010-07-09

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 20

Registration Number: NCT01159275

Locations: 🇹🇭
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Pharmacokinetics of Low Dose Raltegravir

Phase 2

Completed

Conditions: HIV Infections

Interventions: Drug: raltegravir

First Posted Date: 2010-07-09

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 24

Registration Number: NCT01159132

Locations: 🇹🇭
HIV-NAT, Bangkok, Thailand

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: ATV/r

First Posted Date: 2010-07-09

Last Posted Date: 2016-08-18

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 559

Registration Number: NCT01159223

Locations: 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
🇹🇭
BMA Medical College and Vajira Hospital, Bangkok, Thailand
🇹🇭
Taksin hospital, Bangkok, Thailand

and more 7 locations

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Phase 2

Completed

Conditions: HIV-1 Infections

Interventions: Other: lopinavir/ritonavir

First Posted Date: 2010-06-09

Last Posted Date: 2015-03-26

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 24

Registration Number: NCT01139905

Locations: 🇹🇭
HIV-NAT, Bangkok, Thailand

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Phase 2

Completed

Conditions: Tuberculosis
HIV Infections

Interventions: Drug: LPV/r

First Posted Date: 2010-06-07

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 40

Registration Number: NCT01138202

Locations: 🇹🇭
HIV-NAT Thai Red Cross AIDS Research Center, Bangkok, Thailand

Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)

Completed

Conditions: HIV Infections

First Posted Date: 2010-06-07

Last Posted Date: 2020-07-17

Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

Target Recruit Count: 450

Registration Number: NCT01138267

Locations: 🇹🇭
HIV-NAT Thai Red Cross AIDS Research Center, Bangkok, Thailand

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy